Lenvaxen 4 mg & 10 mg Side Effects
Lenvaxen 4 mg and 10 mg contain lenvatinib, a targeted anticancer medicine used for certain types of cancer. Although lenvatinib can be an important part of cancer treatment, it may cause side effects ranging from tiredness, diarrhea, and nausea to serious complications involving blood pressure, the kidneys, the liver, the heart, or bleeding. Understanding Lenvaxen […]
Lenvaxen 4 mg uses
Parameter Clinical Specification Active Pharmaceutical Ingredient (API) Lenvatinib Mesylate INN (equivalent to 4 mg Lenvatinib free base) Innovator Reference Drug Lenvima® (Eisai Co., Ltd. / Merck & Co.) Manufacturer Everest Pharmaceuticals Ltd. Pharmacological Class Multi-Targeted Receptor Tyrosine Kinase (RTK) Inhibitor / Anti-Angiogenic Primary Molecular Targets VEGFR1 (FLT1), VEGFR2 (KDR), VEGFR3 (FLT4), FGFR1–4, PDGFRα, KIT, RET […]